Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27073036 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Irina Honin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Histone Deacetylases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, CAS, MEYS CR.
Abstract (Originalsprache)
Histone deacetylases (HDACs) 1–3 are key regulators of gene expression and represent important therapeutic targets in cancer, neurodegenerative, and immune disorders. Many potent class I HDAC inhibitors display slow- and tight-binding kinetics, which profoundly influence their efficacy and pharmacodynamics. In particular, their dissociation rate (off-kinetic) is critical, since prolonged target engagement greatly influences drug efficacy in vivo. However, the off-kinetics of HDAC inhibitors are often overlooked in the early stages of drug development. Here, we investigated the dissociation kinetics of tucidinostat, trapoxin A, and TNG260 in comparison to the pan-HDAC inhibitor vorinostat. Using biochemical 100-fold jump dilution assays, NanoBRET assays, and cellular washout experiments, we characterized the dissociation of these compounds from purified proteins and in a cellular context. Tucidinostat showed moderately slow off-kinetics, while the clinical candidate TNG260 demonstrated pronounced tight-binding properties. Trapoxin A displayed remarkable discrepancies between assays, as it showed fast dissociation kinetics in the biochemical assay, but tight-binding properties in a cellular setting. These findings not only address the previously unexplored dissociation kinetics of two clinically relevant inhibitors, but also underscore the importance of comprehensive kinetic profiling of novel HDAC inhibitors in cellular models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
- Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, 252 50 Vestec, Czech Republic.
- Bonn Technology Campus, Core Facility 'Gene-Editing', Medical Faculty, University of Bonn, 53127 Bonn, Germany.
ORCID-Profile: Zora Novakova, Simon Schneider, Linda Schäker-Hübner, Cyril Barinka, Finn K. Hansen
Förderung
- German Research Foundation
- CAS
- MEYS CR
- Open Access Publication Fund of the University of Bonn
Zitieren
APA
Honin, I., Novakova, Z., Feller, F., Schneider, S., Schäker-Hübner, L., Barinka, C., & Hansen, F. K. (2026). Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073036
Vancouver
Honin I, Novakova Z, Feller F, Schneider S, Schäker-Hübner L, Barinka C, et al. Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073036
BibTeX
@article{Honin2026,
author = {Honin, Irina and Novakova, Zora and Feller, Felix and Schneider, Simon and Schäker-Hübner, Linda and Barinka, Cyril and Hansen, Finn K.},
title = {Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27073036}
}
EUVIMED